S025
BIPHENOTYPIC SINONASAL SARCOMA: REPORT OF TWO CASES TREATED WITH CARBON-ION RADIOTHERAPY
Radiation / Adjuvant Treatment
Kaoru Takahashi1; Masato Shino2; Kazuaki Chikamatsu2
1Department of Otolaryngology, Isesaki Municipal Hospital; 2Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine
S026
HISTOPATHOLOGICAL ANALYSIS OF NODAL DISEASE AFTER CHEMORADIATION REVEALS VIABLE TUMOR CELLS AS THE MOST IMPORTANT PROGNOSTIC FACTOR IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Aline Golliez1; Grégoire B Morand, Dr, med2; Martina A Broglie2; Panagiotis Balermpas3; Niels J Rupp1
1Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; 2Department of Otorhinolaryngology - Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland; 3Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland
S027
EFFICACY OF PENTOCLO THERAPY IN TREATING HEAD & NECK OSTEORADIONECROSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Arianna V Ramirez, MD1; Janisah A Saripada2; Orly Coblens, MD1; Sepehr Shabani, MD1
1University of Texas Medical Branch Dept of Otolaryngology; 2John Sealy School of Medicine
S028
PROGNOSTIC SIGNIFICANCE OF ACUTE HEMORRHAGE REQUIRING EMBOLIZATION IN THE SETTING OF PREVIOUSLY TREATED HEAD AND NECK SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW AND CASE SERIES
Omar A Karadaghy1; Tuleen Sawaf1; Andrew Peterson2; Celina Virgen1; Bryan Renslo1; Kevin J Sykes1; Jeremy Peterson1; Patrik Pipkorn2; Andres M Bur1
1University of Kansas Medical Center; 2Washington University in St. Louis
S029
HYPOTHYROIDISM POST-RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA
Melissa Foo, Dr; Jeremy Chee, Dr; Donovan Eu, Dr; Thomas Loh, AProf
National University Health System, Singapore
S030
OPIOID ANALGESIC PRESCRIBING PATTERNS FOR PATIENTS UNDERGOING RADIOTHERAPY FOR HEAD AND NECK CANCERS.
Brian Lasonde, PA; Rong Lu, PhD; Saadiya Hawa, MD; Elizabeth Winters; Steven Lai; Savanna Biedermann; Saad A Khan, Assistant Professor
Stanford
S031
THE IMPACT OF HEAD AND NECK MULTIDISCIPLINARY CLINIC ON TREATMENT PACKAGE TIME DURING TWO YEARS OF THE COVID-19 PANDEMIC: A SINGLE INSTITUTIONAL EXPERIENCE
Sobia F Khaja, MD; Christopher T Wilke, MD, PhD
University of Minnesota
S032
MULTICENTER PHASE II TRIAL OF CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY CARBOPLATIN FOR PATIENTS WITH CISPLATIN-INELIGIBLE ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA.
Yushi Ueki, MD1; Shusuke Ohshima1; Yusuke Yokoyama1; Takeshi Takahashi1; Ryusuke Shodo1; Keisuke Yamazaki1; Kohei Ohitaki2; Kohei Saijo1; Ryoko Tanaka1; Takafumi Togashi1; Yuichiro Sato1; Satoshi Takano3; Nao Takahashi3; Ryuichi Okabe3; Arata Horii1
1Niigata University Graduate School of Medicine, Department of Otolaryngology Head and Neck Surgery; 2Niigata Prefectural Cancer Center Hospital Department of Head and Neck Surgery; 3Nagaoka Red Cross Hospital Department of Otorhinolaryngology
S033
TIMELY DELIVERY OF POST-OPERATIVE RADIOTHERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA IN AN UNDERSERVED, SAFETY-NET HOSPITAL PATIENT POPULATION
David J Hernandez, MD
Baylor College of Medicine
S034
QUANTIFICATION OF RADIATION INDUCED FIBROSIS IN HEAD AND NECK CANCER PATIENTS USING SHEAR WAVE ELASTOGRAPHY
Bryan Renslo, BS1; Katherine Yu, MD1; Celina G Virgen, MD, MPH1; Tuleen Sawaf, BS1; Kevin J Sykes, PhD, MPH1; Sufi M Thomas, PhD1; Jill Jones, MD2; Andrés M Bur, MD1
1University of Kansas Medical Center Department of Otolaryngology-Head & Neck Surgery; 2University of Kansas Medical Center Department of Radiology
AHNS 11th International Conference on
Head and Neck Cancer
July 8-12, 2023
Palais des congrès de Montréal
Montréal, QC